相关实验视频
Updated: Jul 26, 2025

10:43
Evaluating In Vitro DNA Damage Using Comet Assay
Published on: October 11, 2017
37.8K
泰莫佐洛米德使ARID1A突变癌症对PARP抑制剂产生敏感性
Zheng-Cheng Yu1,2,3, Tianhe Li1,2,3, Ellen Tully1,2,3
1Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Cancer research
|June 12, 2023
概括
卵巢癌中的ARID1A突变会影响DNA修复. 将temozolomide与PARP抑制剂相结合利用了这一缺陷,导致合成致死性,并在临床前模型中抑制瘤生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- ARID1A是一种SWI/SNF染色体重塑子单元,在子宫内膜癌中经常发生突变,包括卵巢和子宫清细胞癌 (CCC) 和子宫内膜癌 (EMCA).
- 功能丧失的ARID1A突变破坏了表观遗传调节,细胞循环控制和DNA损伤修复途径.
- 缺乏ARID1A的细胞会积累DNA基损伤和基底部部位,表明基底切除修复 (BER) 功能受损.
研究的目的:
- 在ARID1A突变的癌症中,研究结合temozolomide (TMZ) 与多 (ADP-ribose) 聚合酶抑制剂 (PARPi) 的治疗潜力.
- 阐明这种药物组合引起的合成致死性的潜在机制.
主要方法:
- 在ARID1A缺乏细胞中评估DNA损伤和修复动力学.
- 在试验室和体内使用卵巢癌模型评估TMZ和PARPi联合治疗的疗效.
- 对DNA双链断裂,复制应激和亡诱导的分析.
主要成果:
- 缺少ARID1A导致累积的DNA基损伤和延迟的BER.
- 虽然TMZ单疗是无效的,但TMZ和PARPi的组合在ARID1A缺乏细胞中诱导了显著的DNA双链断裂,复制应激和复制叉不稳定性.
- TMZ和PARPi组合强烈抑制了ARID1A突变卵巢瘤异种移植的体内生长,诱导了细胞亡和复制应激.
结论:
- 泰莫索洛米德和PARP抑制剂的组合代表了对ARID1A突变癌症的有希望的合成致命策略.
- 这种方法利用ARID1A失活瘤中的特定DNA修复漏洞来增强治疗反应.
- 需要进一步的临床验证,以探索这种组合在患者中的疗效.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

